Human T- and B-cell reactivity to the 16 kDa α-crystallin protein of Mycobacterium tuberculosis

Scandinavian Journal of Immunology

Volumn 48, Issue 4, 1998, Pages 403-409

  Wilkinson, R J ^a,b,f   Wilkinson, K A ^b,f   De Smet, K A L ^b,g   Haslov, K ^c   Pasvol, G ^a   Singh, M ^d   Svarcova, I ^e   Ivanyi, J ^a,h  

^a NORTHWICK PARK HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c STATENS SERUM INSTITUT   (Denmark)

^d HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^e UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

^f CASE WESTERN RESERVE UNIVERSITY   (United States)

^g ST MARY S HOSPITAL   (United Kingdom)

^h GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BCG VACCINE; CRYSTALLIN; GAMMA INTERFERON; INTERLEUKIN 10; MYCOBACTERIUM ANTIGEN; RECOMBINANT PROTEIN;

ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; BCG VACCINATION; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; GUINEA PIG; HUMAN; HUMAN CELL; INTRADERMAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TUBERCULOSIS;

ANTIGEN PRESENTATION; ANTIGENS, BACTERIAL; B-LYMPHOCYTES; CRYSTALLINS; HUMANS; LYMPHOCYTE COOPERATION; MYCOBACTERIUM TUBERCULOSIS; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; T-LYMPHOCYTES;

EID: 0031721317     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1998.00420.x     Document Type: Article

References (35)

1. Jackett PS, Bothamley GH, Batra HV, Mistry A, Young DB, Ivanyi J. Specificity of antibodies to Immunodominant mycobacterial antigens in pulmonary tuberculosis. J Clin Microbiol 1988;26:2313-8.
2. Vordermeier HM, Harris DP, Lathigra R, Román E, Moreno C, Ivanyi J. Recognition of peptide epitopes of the 16000 MW antigen of Mycobacterium tuberculosis by murine T cells. Immunology 1993;80:6-12.
3. Friscia G, Vordermeier HM, Pasvol G, Harris D, Moreno C, Ivanyi J. Human T cell responses to peptide epitopes of the 16kD antigen in tuberculosis. Clin Exp Immunol 1995;102:53-7.
4. Lee B-Y, Hefta SA, Brennan PJ. Characterisation of the major membrane protein of virulent M. tuberculosis. Infect Immun 1992; 60:2066-74.
5. Cunningham A, Spreadbury C. Mycobacterial stationary phase induced by low oxygen tension: cell wall thickening and localization of the 16-kilodalton alpha-crystallin homolog. J Bacteriol 1998;180: 801-8.
6. Yuan Y, Crane DD, Barry CE. Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial α-crystallin homologue. J Bacteriol 1996;178:4484-92.
7. Chang Z, Primm TP, Jakana J et al. Mycobacterium tuberculosis 16kDa antigen (Hsp16.3) functions as an oligomeric structure in vitro to suppress thermal aggregation. J Biol Chem 1996;271:7218-23.
8. Verbon A, Hartskeerl RA, Schuitema A, Kolk AHJ, Young DB, Lathigra R. The 14,000-molecular weight antigen of Mycobacterium tuberculosis is related to the alpha-crystalllin family of low molecular weight heat shock proteins. J Bacteriol 1992;174:1352-9.
9. De Smet KAL, Hellyer TJ, Khan AW, Brown IN, Ivanyi J. Genetic and serovar typing of clinical isolates of the Mycobacterium avium-intracellulare complex. Tuberc Lung Dis 1996;77:71-6.
10. Jurcevic S, Hills A, Pasvol G, Davidson RN, Ivanyi J, Wilkinson RJ. T cell responses to a mixture of Mycobacterium tuberculosis peptides with complementary HLA-DR binding profiles. Clin Exp Immunol 1996;105:416-21.
11. De Smet KAL, Vordermeier HM, Ivanyi J. A versatile system for the production of recombinant chimeric peptides. J Immunol Methods 1994;177:243-50.
12. Hirsch CS, Hussain R, Toossi Z, Dawood G, Shahid F, Ellner JJ. Cross-modulation by transforming growth factor β in human tuberculosis: suppression of antigen-driven blastogenesis and interferon-γ production. Proc Natl Acad Sci USA 1996;93:3193-8.
13. Newport MJ, Huxley CM, Huston S et al. A mutation in the interferon-γ receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996;335:1941-9.
14. Wilkinson RJ, Hasløv K, Rappuoli R et al. Evaluation of the recombinant 38-kilodalton antigen of Mycobacterium tuberculosis as a potential immunodiagnostic reagent. J Clin Microbiol 1997;35: 553-7.
15. Parish C, Liew F. Immune response to chemically modified flagellin. 3. Enhanced cell-mediated immunity during high and low zone antibody tolerance to flagellin. J Exp Med 1972;135:298-311.
16. Huygen K, Van Vooren JP, Turneer M, Bosmans R, Dierckx P, De Bruyn J. Specific lymphoproliferation, gamma interferon production, and serum immunoglobulin G directed against a purified 32 kDa mycobacterial protein antigen (P32) in patients with active tuberculosis. Scand J Immunol 1988;27:187-94.
17. Sousa AO, Salem JI, Lee FK et al. An epidemic of tuberculosis with a high rate of tuberculin anergy among a population previously unexposed to tuberculosis, the Yanomami Indians of the Brazilian Amazon. Proc Natl Acad Sci USA 1997;94:13227-32.
18. Torres M, Mendez SP, Jimenez ZL et al. Comparison of the immune response against Mycobacterium tuberculosis antigens between a group of patients with active pulmonary tuberculosis and healthy household contacts. Clin Exp Immunol 1994;96:75-8.
19. Surcel H-M, Troye-Blomberg M, Paulie S et al. Th1/Th2 profiles in tuberculosis based on proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 1994;81:171-6.
20. Sousa A, Henry S, Maroja F et al. IgG subclass distribution of antibody responses to protein and polysaccharide mycobacterial antigens in leprosy and tuberculosis patients. Clin Exp Immunol 1998;111:48-55.
21. Bass JB Jr. The Tuberculin test. In: Reichmann LB, Hershfield ES, eds. Tuberculosis. A Comprehensive International Approach. New York: Marcel Dekker, 1993:139-148.
22. Aber VR, Allen BW, Mitchison DA, Ayuma P, Edwards EA, Keyes AB. Quality control in tuberculosis bacteriology. 1. Laboratory studies on isolated positive cultures and the efficiency of direct smear examination. Tubercle 1980;61:123-33.
23. Verbon A, Weverling GJ, Kuijper S, Speelman P, Jansen HM, Kolk AH. Evaluation of different tests for the serodiagnosis of tuberculosis and the use of likelihood ratios in serology. Am Rev Respir Dis 1993;148:378-84.
24. Oettinger T, Holm A, Mtoni IM, Andersen AB, Haslov K. Mapping of the delayed-type hypersensitivity-inducing epitope of secreted protein MPT64 from Mycobacterium tuberculosis.. Infect Immun 1995;63:4613-8.
25. Rook G, Hemandez-Pando R. The pathogenesis of tuberculosis. Annu Rev Microbiol 1996;50:259-84.
26. Asherson GL, Dieli F, Sireci G, Salerno A. Role of IL-4 in delayed type hypersensitivity. Clin Exp Immunol 1996;103:1-4.
27. Rook G, Stanford J. Adjuvants, endocrines and conserved epitopes; factors to consider when designing 'therapeutic vaccines'. Int J Immunopharmacol 1995;17:91-102.
28. Andersen P. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect Immun 1994;62:2536-44.
29. Harboe M, Oettinger T, Wiker HG, Rosenkrands I, Andersen P. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun 1996;64:16-22.
30. Kumar V, Bhardwaj V, Soares L, Alexander J, Sette A, Sercarz E. Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon gamma by T cells. Proc Natl Acad Sci USA 1995; 92:9510-4.
31. Roberts A, Sonnenberg M, Ordway D et al. Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. Immunology 1995;85:502-8.
32. Tascon R, Colston MJ, Ragno S, Stavropoulos E, Gregory D, Lowrie DB. Vaccination against tuberculosis by DNA injection. Nature Med 1996;2:888-92.
33. Chan SL. Chemotherapy of tuberculosis. In: Davies PDO, ed. Clinical Tuberculosis. London: Chapman and Hall, 1994:141-156.
34. Colditz GA, Brewer TF, Berkey CS et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994;271:698-702.
35. Ivanyi J, Thole J. Specificity and function of T and B cell recognition in tuberculosis. In: Bloom B, ed. Experimental Tuberculosis. Washington DC: American Society for Microbiology, 1994;437-458.